Neurogene Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Neurogene Inc. (NGNE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 988.53 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-11
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 211.15K shares, a 96.80% increase year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 777.38K shares, a 7.20% increase year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 15.44K shares, a 59.23% decline year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 78.81K shares, a 94.40% increase year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 926.73K shares, a 4.49% increase from fiscal 2024.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 886.87K shares, a 383.60% increase from fiscal 2023.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 183.39K shares, a 94.65% decline from fiscal 2022.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 3.43M shares, a 2.54% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 211.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 988.53K shares 10-Q · filed 2026-08-11 | 1.00M shares derived: sum of 3 quarters · filed 2026-08-11 | 1.08M shares derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | 777.38K shares 10-Q · filed 2026-05-12 | 792.82K shares derived: sum of 2 quarters · filed 2026-05-12 | 871.63K shares derived: sum of 3 quarters · filed 2026-05-12 | 978.92K shares derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2025-12-31 | 15.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 94.25K shares derived: sum of 2 quarters · filed 2026-03-24 | 201.53K shares derived: sum of 3 quarters · filed 2026-03-24 | 926.73K shares 10-K · filed 2026-03-24 | ||
| 2025-09-30 | 78.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 186.10K shares derived: sum of 2 quarters · filed 2025-11-13 | 911.29K shares 10-Q · filed 2025-11-13 | 949.15K shares derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2025-06-30 | 107.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 832.48K shares 10-Q · filed 2025-08-11 | 870.34K shares derived: sum of 3 quarters · filed 2025-08-11 | 910.88K shares derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2025-03-31 | 725.19K shares 10-Q · filed 2025-05-09 | 763.05K shares derived: sum of 2 quarters · filed 2025-05-09 | 803.59K shares derived: sum of 3 quarters · filed 2025-05-09 | 870.41K shares derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2024-12-31 | 37.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 78.40K shares derived: sum of 2 quarters · filed 2025-03-24 | 145.22K shares derived: sum of 3 quarters · filed 2025-03-24 | 886.87K shares 10-K · filed 2025-03-24 | ||
| 2024-09-30 | 40.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | 107.36K shares derived: sum of 2 quarters · filed 2024-11-18 | 849.01K shares 10-Q · filed 2024-11-18 | 980.30K shares derived: sum of 4 quarters · filed 2024-11-18 | ||
| 2024-06-30 | 66.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 808.47K shares 10-Q · filed 2024-08-09 | 939.76K shares derived: sum of 3 quarters · filed 2024-08-09 | 731.36K shares derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2024-03-31 | 741.65K shares 10-Q · filed 2024-05-10 | 872.94K shares derived: sum of 2 quarters · filed 2024-05-10 | 664.54K shares derived: sum of 3 quarters · filed 2024-05-10 | 814.54K shares derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2023-12-31 | 131.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -77.11K shares derived: sum of 2 quarters · filed 2024-03-18 | 72.89K shares derived: sum of 3 quarters · filed 2024-03-18 | 183.39K shares 10-K · filed 2024-03-18 | ||
| 2023-09-30 | -208.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -58.40K shares derived: sum of 2 quarters · filed 2023-11-14 | 52.10K shares 10-Q · filed 2023-11-14 | 122.70K shares derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-06-30 | 150.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 260.50K shares 10-Q · filed 2023-08-10 | 331.10K shares derived: sum of 3 quarters · filed 2023-08-10 | 2.61M shares derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2023-03-31 | 110.50K shares 10-Q · filed 2023-05-08 | 181.10K shares derived: sum of 2 quarters · filed 2023-05-08 | 2.46M shares derived: sum of 3 quarters · filed 2023-05-08 | 2.83M shares derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2022-12-31 | 70.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 2.35M shares derived: sum of 2 quarters · filed 2023-03-20 | 2.72M shares derived: sum of 3 quarters · filed 2023-03-20 | 3.43M shares 10-K · filed 2023-03-20 | ||
| 2022-09-30 | 2.28M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 2.64M shares derived: sum of 2 quarters · filed 2022-11-14 | 3.36M shares 10-Q · filed 2022-11-14 | 3.69M shares derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2022-06-30 | 364.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 1.08M shares 10-Q · filed 2022-08-09 | 1.41M shares derived: sum of 3 quarters · filed 2022-08-09 | 3.38M shares derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2022-03-31 | 715.50K shares 10-Q · filed 2022-05-09 | 1.04M shares derived: sum of 2 quarters · filed 2022-05-09 | 3.01M shares derived: sum of 3 quarters · filed 2022-05-09 | 3.92M shares derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2021-12-31 | 326.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 2.30M shares derived: sum of 2 quarters · filed 2022-03-01 | 3.21M shares derived: sum of 3 quarters · filed 2022-03-01 | 3.35M shares 10-K · filed 2022-03-01 | ||
| 2021-09-30 | 1.97M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 2.88M shares derived: sum of 2 quarters · filed 2021-11-04 | 3.02M shares 10-Q · filed 2021-11-04 | 3.42M shares derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2021-06-30 | 909.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 1.05M shares 10-Q · filed 2021-08-05 | 1.45M shares derived: sum of 3 quarters · filed 2021-08-05 | 2.74M shares derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2021-03-31 | 140.80K shares 10-Q · filed 2021-05-12 | 539.10K shares derived: sum of 2 quarters · filed 2021-05-12 | 1.83M shares derived: sum of 3 quarters · filed 2021-05-12 | 2.25M shares derived: sum of 4 quarters · filed 2021-05-12 | ||
| 2020-12-31 | 398.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 1.69M shares derived: sum of 2 quarters · filed 2021-03-25 | 2.11M shares derived: sum of 3 quarters · filed 2021-03-25 | 2.40M shares 10-K · filed 2021-03-25 | ||
| 2020-09-30 | 1.29M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 1.72M shares derived: sum of 2 quarters · filed 2020-11-09 | 2.01M shares 10-Q · filed 2020-11-09 | 5.72M shares derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2020-06-30 | 421.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | 711.70K shares 10-Q · filed 2020-08-12 | 4.43M shares derived: sum of 3 quarters · filed 2020-08-12 | 4.73M shares derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2020-03-31 | 290.70K shares 10-Q · filed 2020-05-06 | 4.01M shares derived: sum of 2 quarters · filed 2020-05-06 | 4.31M shares derived: sum of 3 quarters · filed 2020-05-06 | 4.31M shares derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2019-12-31 | 3.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 4.02M shares derived: sum of 2 quarters · filed 2020-03-12 | 4.02M shares derived: sum of 3 quarters · filed 2020-03-12 | 4.02M shares 10-K · filed 2020-03-12 | ||
| 2019-09-30 | 298.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 298.00K shares derived: sum of 2 quarters · filed 2019-11-13 | 298.00K shares 10-Q · filed 2019-11-13 | 300.10K shares derived: sum of 4 quarters · filed 2019-11-13 | ||
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-01 | 0.00 shares 10-Q · filed 2019-08-01 | 2.10K shares derived: sum of 3 quarters · filed 2019-08-01 | 1.09M shares derived: sum of 4 quarters · filed 2019-08-01 | ||
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-07 | 2.10K shares derived: sum of 2 quarters · filed 2019-05-07 | 1.09M shares derived: sum of 3 quarters · filed 2019-05-07 | 1.27M shares derived: sum of 4 quarters · filed 2019-05-07 | ||
| 2018-12-31 | 2.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 1.09M shares derived: sum of 2 quarters · filed 2019-03-07 | 1.27M shares derived: sum of 3 quarters · filed 2019-03-07 | 2.06M shares 10-K · filed 2019-03-07 | ||
| 2018-09-30 | 1.09M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 1.27M shares derived: sum of 2 quarters · filed 2018-11-07 | 2.05M shares 10-Q · filed 2018-11-07 | 2.10M shares derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2018-06-30 | 175.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 963.34K shares 10-Q · filed 2018-08-08 | 1.00M shares derived: sum of 3 quarters · filed 2018-08-08 | 1.02M shares derived: sum of 4 quarters · filed 2018-08-08 | ||
| 2018-03-31 | 787.49K shares 10-Q · filed 2018-05-08 | 828.24K shares derived: sum of 2 quarters · filed 2018-05-08 | 845.99K shares derived: sum of 3 quarters · filed 2018-05-08 | 928.93K shares derived: sum of 4 quarters · filed 2018-05-08 | ||
| 2017-12-31 | 40.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 58.50K shares derived: sum of 2 quarters · filed 2018-03-12 | 141.44K shares derived: sum of 3 quarters · filed 2018-03-12 | 837.54K shares 10-K · filed 2018-03-12 | ||
| 2017-09-30 | 17.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 100.69K shares derived: sum of 2 quarters · filed 2017-11-08 | 796.79K shares 10-Q · filed 2017-11-08 | 881.54K shares derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2017-06-30 | 82.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 779.04K shares 10-Q · filed 2017-08-08 | 863.79K shares derived: sum of 3 quarters · filed 2017-08-08 | |||
| 2017-03-31 | 696.10K shares 10-Q · filed 2017-05-09 | 780.85K shares derived: sum of 2 quarters · filed 2017-05-09 | ||||
| 2016-12-31 | 84.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | 658.71K shares 10-K · filed 2017-03-09 | ||||
| 2016-09-30 | 573.96K shares 10-Q · filed 2016-11-09 | |||||
| 2014-08-07 | 9.00K shares 10-Q · filed 2014-11-04 | |||||
| 2014-05-08 | 175.50K shares 10-Q · filed 2014-11-04 | 175.50K shares 10-Q · filed 2014-08-11 | ||||
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-13 | |||||
| 2013-06-25 | 6.51K shares 10-Q · filed 2014-11-04 | |||||
| 2013-05-30 | 3.91K shares 10-Q · filed 2014-11-04 | |||||
| 2013-04-08 | 13.02K shares 10-Q · filed 2014-11-04 | |||||
| 2013-04-02 | 39.32K shares 10-Q · filed 2014-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |